Thema
Journal Article
18
Research Support, Non-U.S. Gov't
11
Multiple myeloma
10
Multicenter Study
6
Randomized Controlled Trial
5
Adverse events
4
Ixazomib
4
Maintenance therapy
4
Safety
4
11096-26-7
3
4Z8R6ORS6L
3
7S5I7G3JQL
3
Adis International Limited
3
Autologous stem cell transplantation
3
Biomarkers
3
Clin Oncol
3
Klinische Studie
3
Clinical Trial, Phase II
3
Clinical Trial, Phase III
3
Comparative Study
3
Dexamethasone
3
Erythropoietin
3
Flow cytometry
3
Hemoglobins
3
High Dose Chemotherapy
3
Melphalan
3
Minimal residual disease
3
Multiple Myeloma
3
Novel drugs
3
Overall survival
3
Pamidronate
3
Q41OR9510P
3
Thalidomide
3
143011-72-7
2
69G8BD63PP
2
Bortezomib
2
Granulocyte Colony-Stimulating Factor
2
Immunoglobulins
2
M-proteins (Myeloma)
2
Prednisone
2
VB0R961HZT
2
15UQ94PT4P
1
71050168A2
1
72X6E3J5AR
1
9007-73-2
1
Antineoplastic Agents
1
Antineoplastic Agents, Alkylating
1
Antineoplastic Agents, Hormonal
1
Biomarkers, Tumor
1
Blood Proteins
1
mehr ...